Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Ramipril is a prodrug form of the angiotensin-converting enzyme (ACE) inhibitor ramiprilat (Item No. 15557).1 Ramipril (2.5 mg/kg per day, p.o.) reduces systolic blood pressure in spontaneously hypertensive rats.2 It reduces aortic valve backscatter and improves aortic flow in a rabbit model of aortic valve stenosis.3 Ramipril also decreases paw swelling and serum levels of TNF-α and prostaglandin E2 (PGE2) as well as cardiac collagen deposition and fibrosis in a rat model of adjuvant-induced arthritis.4
WARNING This product is not for human or veterinary use.
1. Protease inhibitors: Current status and future prospects. J. Med. Chem. 43(3), 305-341 (2000).
2. Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension. Hypertension 26(2), 236-243 (1995).
3. Ramipril retards development of aortic valve stenosis in a rabbit model: Mechanistic considerations. Br. J. Pharmacol. 162(3), 722-732 (2011).
4. Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis. Arthritis Res. Ther. 14(5), R223 (2012).